In the last three months, 11 analysts have published ratings on NOV NOV, offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 4 | 1 | 2 | 0 |
| Last 30D | 1 | 1 | 0 | 0 | 0 |
| 1M Ago | 3 | 2 | 1 | 1 | 0 |
| 2M Ago | 0 | 1 | 0 | 1 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for NOV, revealing an average target of $21.0, a high estimate of $25.00, and a low estimate of $16.00. This current average represents a 9.4% decrease from the previous average price target of $23.18.
Interpreting Analyst Ratings: A Closer Look
The perception of NOV by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Charles Minervino | Susquehanna | Lowers | Positive | $21.00 | $22.00 |
| Stephen Gengaro | Stifel | Lowers | Buy | $24.00 | $25.00 |
| David Anderson | Barclays | Lowers | Underweight | $17.00 | $20.00 |
| Saurabh Pant | B of A Securities | Lowers | Buy | $20.00 | $22.00 |
| Stephen Gengaro | Stifel | Lowers | Buy | $25.00 | $26.00 |
| Charles Minervino | Susquehanna | Lowers | Positive | $22.00 | $26.00 |
| Phillip Jungwirth | BMO Capital | Lowers | Market Perform | $20.00 | $22.00 |
| Scott Gruber | Citigroup | Lowers | Buy | $21.00 | $24.00 |
| Arun Jayaram | JP Morgan | Lowers | Overweight | $22.00 | $23.00 |
| Roger Read | Wells Fargo | Lowers | Underweight | $16.00 | $20.00 |
| Elizabeth Porter | Morgan Stanley | Lowers | Overweight | $23.00 | $25.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NOV. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for NOV's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into NOV's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on NOV analyst ratings.
Unveiling the Story Behind NOV
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
Key Indicators: NOV's Financial Health
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: NOV's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 5.88%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: NOV's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.2% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): NOV's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.58%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): NOV's ROA stands out, surpassing industry averages. With an impressive ROA of 2.0%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: NOV's debt-to-equity ratio is below the industry average. With a ratio of 0.38, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: Simplified
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
